PROF.DR. FÜSUN GEDİZ

• İzmir Bozyaka Eğitim Araştırma Hastanesi – İç Hastalıkları
• Ege Üniversitesi Tıp Fakültesi – Hematoloji
• İzmir Katip Çelebi Üniversitesi Tıp Fakültesi, Atatürk Eğitim Araştırma Hastanesi - İç Hastalıkları

• İzmir Tabip Odası
• Türk İç Hastalıkları Uzmanlık Derneği
• Türk Hematoloji Derneği (THD)
• EHA (European Hematology Association)
• Ulusal Aferez Derneği Hematoloji Onkoloji Derneği (HOD)

• Erbaycu A E, Karasu I, Ozdemirkıran F G, Yücel N,Özsöz A, Bilgir O. Endobronchial Low-Grade Malt Lymphoma Causing Unilateral Hypertranslucency. Monaldi Archives for Chest Disease.61:4,237-240,2004
• Bilgir F, Bilgir O, Kebapcilar L, Calan M, Ozdemirkiran F, Cinali T, Bozkaya G. Soluble CD40 ligand, high sensitive C-reactive protein and fetuin-A levels in patients with essential thrombocythemia.Transfusion and Apheresis Science Volume 46, Issue 1 , Pages 67-71,February,2012. Doi 10.1016/j.transci.2011.11.013
• Ozdemirkiran F, Cicek C, Pullukcu H, Cagirgan S, Tombuloglu M,Vural F, Saydam G Assessment of hematology patients with confirmed h1n1 positivity . Turk J Med Sci 2012; 42(Sup.2): 1538-1541. Doi 10.3906/sag-1107-23
• Ozdemırkıran F, Gokgoz Z, Ozsan N, Hekımgıl M, Vural F and Cagırgan S. Prominent Reactive Plasmacytic Proliferation Presenting with Transient Pancytopenia: An Unusual Case. J Hematol. Thrombo Dis 2013, 1:117 Volume 1 • Issue 4 • 1000117 .Doi 10.4172/2329-8790.1000117
• Çekiç C, Gümüş Z Z, Akay H S, Ozdemirkiran F, Vatansever S, Ünsal B. Primary lymphoma of colon: a case report. Journal of Palliative Medicine 2013; 5(3): 120–122
• Sahin F, Yilmaz A F, Comert M, Ozdemirkiran F, Gokmen N M , Saydam G. Spontaneous Remission of Paroxysmal Nocturnal Hemoglobinuria During Eculizumab Treatment. Journal of Hematology, Vol. 3, No. 2, Jun 2014.Doi 10.14740/jh120w
• Kucukzeybek BB, Calli AO, Kucukzeybek Y, Bener S, Dere Y, Dirican A, Payzin KB, Ozdemirkiran F, Tarhan MO The prognostic significance of bone marrow metastases: evaluation of 58 cases.Indian J Pathol Microbiol. 2014 Jul-Sep;57(3):396-9. Doi: 10.4103/0377-4929.138728.
• Payzin KB, Savasoglu K, Alacacioglu I, Ozdemirkiran F, Mutlu BB, Bener S, Calli AO, Kucukzeybek BB, Aksun S. JAK2 V617F mutation status of 232 patients diagnosed with chronic myeloproliferative neoplasms.Clin Lymphoma Myeloma Leuk. 2014 Dec;14(6):525-33. Doi: 10.1016/j.clml.2014.02.013. Epub 2014 Mar 5.
• Ozdemirkiran F, Payzin Bayman K B, Kiper H D, Kabukçu S, Çağlıyan GA, Kahraman S, Sevindik Ö G,Ceylan C, Kadıköylü G, Şahin F, Keskin A, Arslan O, Özcan M A, Bolaman Z, Büyükkeçeci F, Bilgir O, Alacacıoğlu İ, Vural F, Tombuloğlu M, Gokgoz Z, Saydam G. Eltrombopag for the treatment of immune thrombocytopenia (ITP): The Aegean Region of Turkey Experience: Turkish Journal of Hematology. Doi: 10.4274/Tjh.2014.0152
• Ozdemirkiran F G, Nalbantoglu S, Gokgoz Z, Payzin B K, Vural F, Cagırgan S, Berdeli A Fas/FasL gene polymorphism in Turkish patients with chronic myeloproliferative disorders. Archives of Medical Science. Doi10.5114/aoms.2015.53963
• Ozdemirkiran F, Oruk G, Payzın B K, Gumus Z, Koruyucu M, Atasever T, Kucukzeybek B, Esen E,Rapidly Growing Thyroid Mass : An Unusual Case of Acute Lymphoblastic Leukemia. Turk J Hematol 2015;32:275-280. Doi 10.4274/tjh.2015.0136
• Alacacioglu I1, Medeni SS, Ozsan GH, Payzin B, Sevindik OG, Acar C, Katgi A, Ozdemirkıran F, Piskin O, Ozcan MA, Undar B, Demirkan F.Is the BFM Regimen Feasible for the Treatment of Adult Acute Lymphoblastic Leukemia? A Retrospective Analysis of the Outcomes of BFM and Hyper-CVAD Chemotherapy in Two Centers. 2015 2014;60(4):219-23. Doi: 10.1159/000375258. Epub 2015 Apr 3.
• Savasoglu K, Payzin KB, Ozdemirkiran F, Berber B. Effectiveness of Quantitative Real Time PCR in Long-Term Follow-up of Chronic Myeloid Leukemia Patients. Journal of the College of Physicians and Surgeons Pakistan 2015, Vol. 25 (8): 568-572.Doi 08.2015/JCPSP.568572.
• Özdemirkıran F, Çoban E, Payzın B K, Bayram K B . Acute lymphoid leukemia in a patient wıth ankylosing spondylitis after antı-tnf-alpha treatment: case report. Doi: 10.5606/ArchRheumatol.2015.5669Arch Rheumatol 2015;30(4):349-352
• Soyer N, Haznedaroğlu İC, Cömert M, Çekdemir D, Yılmaz M, Ünal A, Çağlıyan G, Bilgir O, İlhan O, Özdemirkıran F, Kaya E, Şahin F, Vural F, Saydam G. Multicenter-Retrospective Analysis Of Turkish Patients With Chronic Myeloproliferative Neoplasms.Turk J Haematol. 2016 Apr 18. doi: 10.4274/tjh.2016.0005
• Savasoglu K1, Payzin KB2, Ozdemirkiran F2, Subasioglu A1, Yilmaz AF2.
• The effect of the additional cytogenetic abnormalities on major molecular response and BCR-ABL kinase domain mutations in long-term follow-up chronic myeloid leukemia patients, a cross sectional study. Leuk Lymphoma.2016 Dec 7:1-5. [Epub ahead of print]
• Gediz F1, Payzin BK2, Ecemis S3, Güler N2, Yilmaz AF2, Topcugil F3, Berdeli A4. Efficacy and safety of eculizumab in adult patients with atypical hemolytic uremic syndrome: A Single center experience from Turkey.Transfus Apher Sci.2016 Dec; 55(3):357-362. doi: 10.1016/j.transci.2016.09.017. Epub 2016 Sep 30.
• Gediz F, Payzin K B,Cakmak Ö Z, Uzum Y, Ernur D, Sahin F, Paroxysmal nocturnal hemoglobinuria in the differential diagnosis of thrombocytopenia. PNH Trombositopeni, Hematology Reports Hematology Reports 2017; 9:6862
• Gediz F, Yılmaz AF, Payzın B, Yüksel T, Aycan H, Kobak Ş. Development of Hodgkin lymphoma in a patient with sarcoidosis. Reumatismo. 2017 Aug 3;69(2):84-87. doi: 10.4081/ reumatismo.2017.916
• Küçükzeybek B B, Çallı A Ö, Uyaroğlu M A, Ozdemirkiran F, Sarı A A, Vatansever A, Payzın B.CD3 Positive Gastric Plasmablastic Lymphoma in a HIV-Negative Patient: A Case Report. Journal of Clinical and Experimental Investigations. 2017; 8(1):35‐38
• Yilmaz F, Gediz F, Kiper D. A healthy baby born under the treatment of Eculizumab in a PNH patient after two fetal losses: Turkish Eculizumab baby. Izmir Katip Celebi University, Ataturk Education and Research Hospital, Izmir, Turkey. Kuwait Medical Journal 2018; 50 (4): 470 - 472
• Yılmaz F, Kiper D, Koc M ̧ Karslı T, Kılınc M,Gediz F, Toptas T, Payzın B. Clinical Features and Treatment Outcomes of Warm Autoimmune Hemolytic Anemia: A Retrospective Analysis of 60. Turkish Patients Indian J Hematol Blood Transfus https://doi.org/10.1007/s12288-019-01103-y02.2019
• Gediz F, Kobak S. Immune Checkpoint Inhibitors-related Rheumatic Diseases: What Rheumatologist Should Know?Curr Rheumatol Rev. 2019;15(3):201-208. doi: 10.2174/1573397115666190119094736.
• Yılmaz F, Karslı T, Kiper D, Gediz F,Payzın B. Is It Rational to Study Coagulations Test Routinely before Operations and Invasive Procedure: Single Center Retrospective Study. International Journal of Hematology-Oncology and Stem Cell Research. 2019 Jul 1;13(3):140-145.
• Cekdemir D, Guvenc S, Ozdemirkiran F, Eser A, Toptas T, Ozkocaman V, Haydaroglu Sahin H, Ermis Turak E, Esen R, Comert M, Sadri S, Aslaner M, Uncu Ulu B, Karakus A, Selim Bapur D, Alacacioglu I, Aydin D, Tekinalp A, Namdaroglu S, Ceran F, Tarkun P, Kiper D, Cetiner M, Yenerel M, Demir AM, Yilmaz G, Terzi H, Atilla E, Malkan UY, Acar K, Ozturk E, Tombak A, Sunu C, Salim O, Alayvaz N, Sayan O, Ozan U, Ayer M, Gokgoz Z, Andic N, Kizilkilic E, Noyan F, Ozen M, Pepedil Tanrikulu F, Alanoglu G, Ozkan HA, Aslan V, Cetin G, Akyol Erikci A, Deveci B, Ersoy Dursun F, Dermenci H, Aytan P, Gunduz M, Karakus V, Ozlu C, Demircioglu S, Akay Yanar OM, Ozatli D, Undar L, Tiftik EN, Turkoz Sucak AG, Haznedaroglu I, Ozcan M, Sencan M, Tombuloglu M, Ozet G, Bilgir O, Turgut B, Ozcan MA, Payzın KB, Sonmez M, Ayyildiz O, Dal MS, Ertop S, Turgut M, Soysal T, Kaya E, Unal A, Pehlivan M, Atagunduz I, Tuglular Firatli T, Saydam G, Diz Kucukkaya R. A multi-centric study on the efficacy of eltrombopag in management of refractory chronic immune thrombocytopeniaTurk J Haematol. 2019 Jul 22. doi: 10.4274/tjh.galenos. 2019.2018.0307.
• Namdaroglu S, Yıldırım G, Gediz F, Bilgir O.Evaluation of hepatitis B markers and reactivation of hepatitis B infection in non-hodgkin lymphoma patients treated with rituximab: A single-center study. Journal of Phlebology & Lymphology . 2020, Vol. 13 Issue 1, p12-16. 5p.
• Gediz F, Oruk GG, Korkmaz UB, Aksun S, Calan M, Savasoglu K, Yilmaz AF, Payzin KB.
• A possible connection between circulating 25-hydroxy-vitamin D and molecular response in chronic myeloid leukemia.Bratisl Lek Listy. 2020;121(5):366-369. doi: 10.4149/BLL_2020_059.
  
  Soyer N, Alİ R, Turgut M, HaznedaroĞlu İC, Yilmaz AF, AydoĞdu İ, Pİr A, KarakuŞ V, ÖzgÜr G, KİŞ C, Ceran F, İlhan G, Özkan M, Aslaner M, İnce İ, YavaŞoĞlu İ, Gediz F, SÖnmez M, GÜvenÇ B, Özet G, Kaya E, Vural F, Şahİn F, TÖbÜ M, Durusoy OnmuŞ İR, Saydam G.Efficacy and safety of ruxolitinib in patients with myelofibrosis: a retrospective and multicenter experience in Turkey.Turk J Med Sci. 2020 Dec 14. doi: 10.3906/sag-1812-70. Online ahead of print.
• Gediz F, UgurMC, Turkmen M, Kobak S. Ustekinumab-induced chronic lymphocytic leukemia in a patient with psoriatic arthritis. Reumatologia 2021; 59, 1: 1–4 DOI: https://doi.org/10.5114/reum.2021.102618
• CetintepeT, Cetintepe L, Solmaz S, Calık S, Ugur MC, Gediz F, Bilgir O. Determination of the relationship between mortality and SOFA, qSOFA, MASCC scores in febrile neutropenic patients monitored in the intensive care unit. Supportive Care in Cancer https://doi.org/10.1007/s00520-020-05924-w
• Ugur MC, Gediz FEvaluation of patients diagnosed with psoriasis and multiple myeloma after autologous stem cell transplantation.Transfus Apher Sci. 2021 Apr 8:103137. doi: 10.1016/j. transci.2021.103137.
• Baysal E, Sari D, Vural F, Çağırgan S, Saydam G, Töbü M, Şahin F, Soyer N, Gediz F, Acarlar C, Timur E, Güngör A.pH Value in Multiple Myeloma Patients Undergoing Autologous Stem Cell Transplantation.Semin Oncol Nurs. 2021 May 15:151146. doi: 10.1016/j.soncn.2021.151146. Online ahead of print.

Ödüller

• Türk Hematoloji Derneği Genç Katılımcı Ödülü. ‘’ Dirençli kronik immun trombositopenik purpura nedeni ile rituximab uygulanan olgularımız’’.
  Ulusal Hematoloji Kongresi 3-7 Kasım 2010, Antalya Türk Hematoloji Derneği Türkba ödülü.
• ‘’Ülkemizde İmmun trombositopenide eltrombopag kullanımı’’ 41. Ulusal Hematoloji Kongresi 21-25 Ekim 2015, Antalya
  Hematolojik Onkoloji ve Kemik iliği Transplantasyon Sempozyumu, bildiri teşvik ödülü
• 3-6 Şubat 2016 KKTC
  .Hematolojik Onkoloji Kongresi, en iyi bildiri dalında üçüncülük ödülü. 21-25 Eylül 2016 K.K.T.C.